i'll find out from barclays' head of european pharmaceutical research — that's emily field — and therch director to some of the world's biggest blue chip companies, toby clark of mintel consulting. plus, later in the show, our big boss is polina veksler, the co—founder and chief executive of universal standard. it makes clothes for those who are size zero to size a0. is the jab juggernaut simply hype or a real game—changer with trillion—dollar consequences? wherever you'rejoining us from, welcome to the programme. now, in 1983, a married couple, jenny and sid craig, opened their first weight—loss centre in melbourne, australia. it grew to be a global company with 700 slimming clubs and a food brand so big that nestle bought it for $600 million. well, last year, after changing hands a few more times, jenny craig filed for bankruptcy. all its employees were let go and the brand name was sold once more. asjenny craig collapsed, the world of weight loss was being revolutionised. in 2018, the drug ozempic was approved to treat diabetes in europe. three years later, the company that makes